分子检测阴性不确定甲状腺结节的非手术结局
该研究基于随机对照试验的前瞻性随访,评估Bethesda III/IV不确定甲状腺结节在分子检测阴性/良性后延迟手术率及假阴性风险。95个结节中83个(87.4%)选择非手术管理,中位监测26.7个月,4个结节确诊恶性,总体假阴性率5.8%。结论提示多数结节临床病程稳定,但约6%假阴性率支持持续超声监测。
要点
- 分子检测阴性不确定结节中87.4%可避免立即手术。
- 中位随访26.7个月,假阴性率5.8%。
- 延迟手术的4例恶性均因超声变化触发。
核心结论
- 多数分子检测阴性的不确定甲状腺结节在约3年随访中临床病程稳定。
- 5.8%的总体假阴性率提示持续超声监测的重要性。
研究设计与样本
- 基于Gene Expression Classifier vs Targeted Next-Generation Sequencing随机对照试验的前瞻性随访。
- 纳入2016年4月至2017年7月UCLA甲状腺活检Bethesda III/IV细胞学患者。
主要发现
- 95个分子检测阴性/良性结节中,12个立即切除(11个良性,1个NIFTP)。
- 83个(87.4%)结节选择非手术管理,中位监测26.7个月。
- 4个延迟手术的恶性结节均由监测中超声变化触发手术。
临床怎么用
- 对分子检测阴性的不确定甲状腺结节可考虑非手术超声监测。
- 监测中需关注超声变化以发现潜在恶性。
局限性
- 需长期研究确定最佳随访时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Molecular testing to refine the diagnosis of cytologically indeterminate thyroid nodules has become increasingly popular, but data on long-term durability of test results and the rate of delayed operation are limited. OBJECTIVE: Determine the delayed rate of surgical resection in indeterminate nodules with benign/negative molecular testing and the risk of false-negative molecular test results. DESIGN: Prospective follow-up of the Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules randomized controlled trial comparing the diagnostic test performance of Afirma Gene Expression Classifier and ThyroSeq v2. SETTING: University of California, Los Angeles. PARTICIPANTS: Patients who underwent thyroid biopsy with indeterminate (Bethesda III/IV) cytology (April 2016 to July 2017). INTERVENTION: Ultrasound surveillance. MAIN OUTCOME MEASURE: False-negative rate of molecular testing. RESULTS: Of 95 indeterminate nodules with negative/benign molecular test results, 12 nodules underwent immediate resection (11 benign nodules, 1 noninvasive follicular thyroid neoplasm nodule with papillary-like nuclear features). Nonoperative management was pursued for 83 (87.4%) nodules. The median surveillance was 26.7 months. Ten nodules were resected during surveillance and malignancy was identified in 4 nodules (overall false-negative rate of 5.8%). In the 4 malignant nodules that underwent delayed operation, surgery was prompted by sonographic changes during surveillance. CONCLUSIONS: The majority of indeterminate nodules with negative molecular testing have a stable clinical course over 3 years of follow-up, but our finding of a 6% false-negative rate highlights the importance of continuing sonographic surveillance. Long-term studies are needed to determine the optimal length of follow-up.
引用
- Zhu CY, Donangelo I, Gupta D, et al. Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing. J Clin Endocrinol Metab. 2021. PMID: 33394039. doi:10.1210/clinem/dgaa887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。